Celicet
A Cefixime brand by Maydon Pharmaceuticals Limited — tablet, made in India.
Ogbogwu is a reference directory quoting the NAFDAC register. We do not sell, dispense or prescribe medicines, and nothing here replaces a doctor or pharmacist.
NAFDAC registration
Our October 2026 copy of the NAFDAC Greenbook lists Celicet Tablets — registration number B4-6916 — with status Active.
Celicet price in Nigeria
Prices for Cefixime products vary by brand, strength, and pack size — check current prices at a licensed pharmacy, or tell us what you need and we'll connect you with a verified source.
Which one are you?
I'm buying Celicet
Tell us what you need and the quantity, and we'll connect you with a verified, NAFDAC-registered source. Free, no obligation.
I sell Celicet
Get a free page where buyers look for them: your products, your number, how to find your shop. Independent of NAFDAC and government. Nothing goes live until you have seen it and approved it. Why list? →
Celicet at a glance
- Generic name
- Cefixime
- Manufacturer
- Maydon Pharmaceuticals Limited
- Made by (factory)
- Baroque Pharmaceuticals Pvt Ltd
- Form
- Tablet
- Strength
- 400 mg· 17 makers
- Made in
- India
- NAFDAC reg. no.
- B4-6916
About Cefixime
Cefixime is an oral third-generation cephalosporin antibiotic. Unlike most third-generation cephalosporins — which are injections given in hospital — cefixime is taken by mouth, which has made it a popular step-up antibiotic in Nigerian outpatient care, especially for typhoid fever. It works by disrupting the bacterial cell wall, and its strength is broad activity against gram-negative bacteria including Salmonella typhi (the cause of typhoid), many E. coli, and Haemophilus influenzae.
Read the full Cefixime guide — dosage, side effects, warnings, and all registered brands.
Frequently asked questions
Registration details are shown exactly as recorded in the NAFDAC Greenbook (our copy: October 2026). Listings can lag renewals — always confirm current status on the official Greenbook before acting on it. Content updated October 2026.